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Background: Asthma is a chronic inflammatory disorder, hypothetically caused by autoreactive 
Th2 cells, whereas Th1 and regulatory T cells may confer protection. The development of 
Th subpopulations is dependent on the expression of lineage-specific transcription factors.
Purpose: This study aimed to assess the balance of CD4+ T cell populations in asthmatic 
children.
Methods: Peripheral blood mononuclear cells (PBMC) mRNA expression was assessed in 
30 asthmatic children (18 patients with mild asthma and 12 with moderate asthma). Real-time 
polymerase chain reaction (RT-PCR) quantified TBX21, GATA-3, RORC, FOXP3, and 
EBI3 mRNA expression. Intracellular cytokine expression of IL-2, IL-4, IL-10, and IFN-γ in 
CD4+ T cells in asthmatic children was measured by flow cytometry. IL-6 and IL-17 cytokines 
were assessed in serum by enzyme-linked immunosorbent assay (ELISA).
Results: A significant increase was found in the percentage of CD4+ and CD8+ T cell-producing 
IL-4, IL-6, and IL-17. A decreased percentage of CD4+ producing IFN-γ in asthmatic children 
was found. Expression of GATA-3 (Th2), retinoid-related orphan receptor C (RORC) (Th17), and 
EBI3 were increased in asthmatic patients compared to healthy controls. Expression of FOXP3 
(Treg) and TBX21 (Th1) were decreased (P , 0.0001 and P , 0.0001) in asthmatic children. 
Analysis of transcription factor ratios revealed an increase in the RORC/FOXP3 (P = 0.0001), 
and a significant decrease of TBX21/GATA-3 (P = 0.0001) ratios in patients with asthma.
Conclusion: Young asthmatics were characterized by increased IL-4 production and low IFN-γ 
synthesis. The increased serum IL-17 and IL-6 levels sustained an inflammatory environment 
in young asthmatics. The results indicate that FOXP3 and RORC mRNA expression could be 
associated with the sustained inflammatory process, transduced by low immune tolerance by Treg 
cells. The TBX21/GATA-3 and RORC/FOXP3 ratios dysregulation in asthmatics is consistent 
with the plasticity existing between Th1, Th17, and Treg cells during inflammation.
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Introduction
Asthma is a chronic inflammatory disorder of the airway.1 Its symptoms are highly 
variable, and the causes of asthma and their interactions remain largely uncertain.2 
The heterogeneity of asthma suggests that it is influenced by a multitude of factors, 
including genetics, family history, age, sex, socioeconomic status, race and/or ethnic-
ity, and a host of recognized environmental factors. The role of specific T cells and 
their cytokines in the pathogenesis of allergic asthma is now well recognized.3 The 
infiltration and accumulation of polarized CD4+ T helper (Th)2 cells, degranulated mast 
cells, and eosinophils in the bronchial mucosa are the pathological features of allergic 
asthma. Allergic asthma starts with an influx of naive CD4+ T cells and eosinophils Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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into the bronchial mucosa. The priming of the naïve CD4+ T 
cells to differentiate into proinflammatory Th2 cells, instead 
of the infection-fighting Th1 cells in the T-cell repertoire, by 
  allergen-activated dendritic cells (DCs) is an important pro-
posed mechanism.4 The progressive increase in the commit-
ment of CD4+ T cells toward a Th2 phenotype is accompanied 
by an upregulation of the Th2 inflammatory cytokines, such 
as IL-4, IL-5, IL-9, and IL-13, and an increased expression of 
the transcriptional factor GATA-3.3 In parallel, the Th2 cells 
shut off the expression of interferon-γ (IFN-γ) and other Th1 
cytokines, such as IL-2. The recent discovery of Th17 in 
the mediation of corticosteroid-resistant asthma sheds new 
light on neutrophilic asthma.5 A skewed programming of 
CD4+ T cells toward Th2 or Th17 phenotype seems to be 
a primary cause of asthma and other immune dysfunctions 
of the airway.
Th1-type cells, defined by secretion of IFN-γ, are primar-
ily involved in host defense against intracellular bacteria. 
Th2-type cells, involved in allergic reactions and defense 
against parasites, are phenotypically recognized by IL-4, 
IL-5, and IL-13 production.6,7 Th17 cells, characterized by 
their secretion of IL-17 A and IL-17F, fill a gap between 
Th1 and Th2, contributing to immunity against certain 
extracellular bacteria and fungi, and are typically linked to 
the defense of mucosal surfaces.8 The Th profile-associated 
cytokines produced are regulated by the expression of subset-
specific transcription factors: TBX21 directs the Th1 cellular 
program;9 while GATA-3 is specific for Th2 cells.10 Recently, 
the human RORC (retinoid-related orphan receptor C) mRNA 
transcript variant 2 was identified, and appears to be responsi-
ble for Th17 differentiation.11 The phenotype of CD4+CD25hi 
regulatory T cells (Tregs) is directed by the transcription 
factor FOXP3, also frequently used as a specific marker 
of these cells.12,13 Tregs have been implicated as playing an 
important role in peripheral tolerance through their ability to 
suppress effector CD4+ T cells. Recently, the cytokine IL-35, 
consisting of EBI3 (Epstein–Barr virus-induced gene 3) and 
p35 (IL-12a), was implicated as a candidate for mediation of 
suppression and a downstream target of FOXP3.14
Asthma has classically been viewed as Th2-type mediated, 
but recent studies have shifted attention toward Th17 cells 
as responsible for the pathological processes.15,16 In order to 
evaluate the balance between CD4+ populations in asthmatics, 
the study examined the expression of the CD4+ T cell-related 
transcription factors in blood from children with mild and 
moderate asthma. In addition, the study assessed cytokines’ 
profile in peripheral CD4+ T cells between asthmatic children 
and healthy controls.
Materials and methods
study subjects
Thirty children with asthma, diagnosed according to the 
Global Initiative for Asthma guidelines,17 were enrolled in the 
study and seen consecutively at the Department of Pediatrics 
and Respiratory Disease, Homeostasis and Cell Dysfunction 
Unit Research 99/UR/08-40, Abderrahman Mami Hospital 
(Ariana, Tunisia). Thirty children without asthma served as 
healthy controls. The Abderrahman Mami Hospital Ethics 
Committee approved the project, and the parents and children 
gave their informed consent to be enrolled in the study. Children 
with mild and moderate asthma were treated with regular 
inhaled glucocorticoids (ICS), but variable daily doses were 
required to control the symptoms (at the time of evaluation 
daily ICS dose ranged 100–1000 mg/day). Nine children with 
exacerbation were excluded from the study. Table 1 describes 
the characteristics of the asthmatic patients in the study: 60.5% 
had mild asthma and 39.5% had moderate asthma. The study 
analyzed TBX21, GATA-3, RORC, FOXP3, and EBI3 mRNA 
transcript in peripheral blood mononuclear cells (PBMC) from 
young asthmatic patients compared to PBMC from healthy 
children (mean age ± SD: 14 ± 3.8 years; range: 4–15 years).
cytokines levels in sera
The serum levels of the proinflammatory cytokines 
IL-6 (pg/mL) and IL-17 (pg/mL) were assessed using a 
solid phase enzyme-linked immunosorbent assay (ELISA), 
as recently reported.18 Commercial ELISA kits were pro-
vided from R&D Systems® (Minneapolis, MN), Genzyme 
  (Cambridge, MA), and BioSource™ (Camarillo, CA). Tests 
were performed according to the manufacturer’s instructions 
for each product (detection limits of IL-6: 0.094 pg/mL, of 
IL-17: 4–15 pg/mL).
Table 1 Patients’ characteristics
Characteristics Data
number of subjects 30
gender: female/male 18/12
Age 9.8 (4–16)
Positive skin test results 68.4%
FVc (%) 88.38 (58–112)
FeV1 (%) 92.74 (53–120)
FeV1/FVc 0.9 (0.79–1)
Passive smoking 47.3%
Severity
Mild 60%
Moderate 40%
cD4/cD8 ratio 1.08 v. (hc)1.1†
Notes: †P = 0.068.
Abbreviations: FeV1, forced expiratory volume in 1 second; FVc, forced vital capacity.Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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Real-time polymerase chain reaction  
(RT-PcR)
RT-PCR was performed on PBMCs. The expression of 
mRNA was quantified using the Applied Biosystems™ 7500 
Fast Real-Time PCR System (Carlsbad, CA), as recently 
reported.19 Amplification of complementary DNA (cDNA) 
was performed with the TaqMan® Universal PCR Master Mix 
(2×), No AmpErase® UNG (Applied Biosystems). A reaction 
volume of 25 µL (1.0 µL cDNA) was amplified for 40 cycles 
of 10 seconds at 95°C, and 1 minute at 60°C. All samples 
were analyzed in duplicate, and transcription expression 
was calculated as a mean and standard deviation (SD). For 
quantification of cDNA, a five-point serially four-fold diluted 
standard curve was developed from cell cultures stimulated 
with phytohemagglutinin. The mRNA expression of the 
T cell transcription factors was standardized to 18S (human 
rRNA) and all results expressed as a ratio. A coefficient of 
variance ,15% was accepted as maximum variation among 
duplicates. The intra-assay variance for 18S was 4.9%; 
FOXP3 6.5%; GATA-3 6.1%; RORC 7.2%; TBX21 7.2%; 
and EBI3 6.2%. Samples revealing an undetectable expres-
sion in both duplicates in three subsequent analyses were 
assigned an expression quantity of zero. Primers and probes 
for TBX21, RORC, and EBI3 expression were analyzed with 
TaqMan Gene Expression assays (Applied Biosystems), 
while GATA-3, FOXP3, and 18S, using 30 FAM/50 
TAMRA™-labeled probes were constructed in-house using 
Primer Express® 3.0 (Applied Biosystems). The following 
sequences were used: GATA-3 forward CAAAATGAACG 
GACAG AACCG, reverse GCTCTCCTGGCTGCAGACA, 
probe CCCCTCATTAAGCCCAAGCGAAGG; FOXP3 
  forward GTGGCCCGGATGTG AGAA, reverse GCTGCTC 
CAGAGACTGTACCATCT, probe CCTCAAGCACTG 
CCAGGCGGAC; 18S forward CGGCTACCACATCCA 
AGGAA, reverse GCTGGAA TTACCGCGGCT, probe 
GAGGGCA AGTCTGGTGCCAGCA. High-performance 
liquid chromatography-purified oligonucleotide primers and 
probes were bought from MedProbe® (Oslo, Norway). All 
in-house-designed mRNA amplicons included at least one 
exon–exon boundary to ensure specificity (marked in bold 
in the sequences above), and reaction concentration was 
optimized prior to analysis of samples.
Intracellular cytokine staining
Intracellular cytokine staining before and after polyclonal 
stimulation was assessed, as recently reported.18 Heparinized 
whole blood was diluted with Gibco® RPMI (Invitrogen™, 
Carlsbad, CA) and 2% calf serum, and after the addition of 
25 µL (25 ng/mL) phorbol 12-myristate 13-acetate (PMA; 
Sigma®, St Louis, MO), 20 µL (1µg/mL) ionomycin (Sigma), 
and 10 µL (2.5 µM) monensin (Sigma) incubated in a water 
bath for 4 hours at 37°C. Stimulated whole blood was 
  distributed in 100 µL aliquots into tubes containing 20 µL 
anti-human CD3 FITC and CD4 PerCp (Becton Dickinson 
[BD], Franklin Lakes, NJ), vortexed, and incubated for 
20 minutes at room temperature in the dark. To fix cells, 
100 µL of IntraPrep Reagent 1 (DAKO, Glostrup, Denmark) 
was added to the samples followed by vortexing and incu-
bation for 15 minutes at room temperature in the dark, and 
washing with 2 mL of cell-wash solution. Simultaneous 
permeabilization of white cells and lysis of red cells was 
then carried out by adding 100 µL IntraPrep Reagent 2 
(DAKO) and incubation. Intracellular staining procedure 
included addition of 20 µL of anti-IL-2, IL-4, IL-10, and 
IFN-γ monoclonal antibodies or isotype control mouse 
antibodies conjugated with   phycoerythrin (DAKO). The 
flow cytometric assessment with FACScan flow cytometry 
(EPICS XL; Coulter Electronics, Hialeah, FL) was performed 
on the same day. Acquisition was gated on CD3+CD4+ and 
CD3+CD8+ cells to define the CD4/CD8 ratio. The percentage 
of CD3+CD4+ cell-producing IL-2, IL-4, IL-10, and IFN-γ, 
was determined on dot plots. The acquisition was performed 
both on samples stimulated with PMA and ionomycin, and 
on nonstimulated samples, in order to estimate the residual 
intracellular expression of the cytokines. Activation of the 
cells was confirmed by estimation of the CD69 expression, 
which was .90% in all samples.
statistical analysis
Data were analyzed with IBM® SPSS® (v 15.0.0; SPSS Inc, 
Chicago, IL). The Mann–Whitney U test was used to analyze 
independent samples for differences in transcription factor 
expression. When assessing flow cytometric data, Student’s 
t-test was used. P values , 0.05 were considered statisti-
cally significant.
Results
expression of FOXP3, gaTa-3, TBX21, 
and RORc in asthmatic children
The study detected the expression of mRNA for GATA-3, 
EBI3, and TBX21, and for FOXP3 in mild asthmatics 
and moderate asthmatics. The results were expressed 
as (mean ± SD). Patients with asthma expressed higher 
Th2-inducing GATA-3 mRNA levels (2.61 ± 1.11; range: 
0.97–5.6) than healthy controls (0.82 ± 0.37; range: 1.2–1.5; Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
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P = 0.0001) (Figure 1A). No significant difference was 
observed between mild and moderate asthmatics (2.30 ± 0.97 
and 2.08 ± 1.4; P = 0.058; P = 0.92) in the Th2-inducing 
GATA-3 mRNA level. In contrast, the FOXP3 was signifi-
cantly decreased in asthmatics (0.51 ± 0.31; range: 0.1–1.72) 
compared to controls (2.75 ± 1.14; range: 1.3–5; P = 0.0001) 
(Figure 1B). The levels of FOXP3 mRNA tended to be lower 
in moderate (0.39 ± 0.21) than mild asthmatic (0.52 ± 0.29) 
patients without any significance (P = 0.068).
The expression of Th1-type TBX21 was significantly 
decreased in mild and moderate asthmatics (0.75 ± 0.42; 
range: 0.13–1.9) compared to healthy controls (2.51 ± 0.98; 
range: 0.9–4.6; P , 0.0001; Figure 1C). No difference 
was found in the Th1-inducing TBX21 mRNA expression 
between mild and moderate asthmatics. By contrast, Th17-
associated RORC was significantly increased in asthmatics 
(3.5 ± 1.19; range: 0.97–6) compared to healthy controls 
(0.44 ± 0.29; range: 0.13–1.8; P , 0.0001; Figure 1D). 
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Figure 1 comparison of transcription factor expression fold change in patients with asthma compared to healthy controls (hc).
Notes: All values represent quotes between transcription factor and 18s expression. In the figure, the horizontal bars within boxes correspond to the median; box limits 
correspond to 25th and 75th percentiles; and vertical lines indicate the range. The mean values were compared and the P values are indicated on the figure. a significant 
difference was observed in eBI3 value between asthmatic patients (3.19 ± 1.48) and healthy controls (1.55 ± 0.81; P = 0.008).Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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Levels of Th17-associated RORC were significantly different 
between mild (4.75 ± 1.19; range: 1.19–4.73) and moderate 
(5.78 ± 0.97; range: 2.6–6) asthmatic patients (P = 0.0032). 
The expression of EBI3 mRNA was significantly increased 
both in mild and moderate asthmatics (3.19 ± 1.48) as com-
pared to controls (1.55 ± 0.81; P = 0.008; Figure 1E).
TBX21 and GATA-3 are regarded as reciprocally inhib-
iting each other.9,20 Similarly, RORC was antagonistically 
related to FOXP3.21 Therefore, the study calculated ratios 
of TBX21/GATA-3 and RORC/FOXP3 in order to assess 
the relative expression of transcription factors (Figure 2). 
The RORC/FOXP3 ratio exhibited a drastic increase in 
asthmatic patients (8.55 ± 6.62) both in mild and mod-
erate asthmatics compared to controls (0.198 ± 0.16; 
P , 0.0001). A significant difference was also observed 
between asthmatic patients (0.34 ± 0.26) and controls 
(4.76 ± 4.81; P = 0.0001) regarding TBX21/GATA-3 ratio. 
As seen in Figure 2, the RORC/TBX21 ratio exhibited a 
drastic increase in asthmatic patients (6.60 ± 4.96) com-
pared to controls (0.20 ± 0.18; P , 0.0001). The balance 
between Treg and Th effector cells regulates the degree of 
inflammation. The increased RORC/TBX21 ratio (Th17/
Th1) was used to mirror the level of the inflammation. 
Comparison of RORC/FOXP3 and RORC/TBX21 revealed 
an imbalance in the subpopulation of CD4+ T cells among 
young asthmatics, with a low expression of Treg-associated 
transcription factors.
serum Il-17 and Il-6 expression  
in asthmatic children
Cytokine levels in sera of IL-6 and IL-17 were expressed as 
mean ± standard error (SE). Values of IL-6 and IL-17 were 
significantly higher in all asthmatic patients compared to 
healthy children (IL-6: 12.9 ± 4.8 pg/mL vs 4.9 ± 2.7 pg/mL 
[P = 0. 0012]; IL-17: 17.6 ± 8.5 pg/mL vs 9.4 ± 3.6 pg/mL 
[P = 0. 0026]). No significant differences were observed in 
asthmatic groups between mild and moderate asthmatics 
(IL-6: 11.7 ± 5.2 pg/mL vs 12.3 ± 1.9 pg/mL [P . 0. 05]; 
IL-17: 16.4 ± 4.3 pg/mL vs 17.2 ± 3.2 pg/mL [P . 0. 05]).
Frequencies of T cell-producing Il-2, Il-4, 
Il-10, and IFn-γ spontaneously and after 
stimulation in asthma patients and healthy 
controls
Mean values of frequencies of CD4+ T cell-producing 
IL-2, IL-4, IL-10, and IFN-γ, before and after stimulation 
are shown in Table 2. Unstimulated CD4+ T cells in whole 
blood staining positively for IL-2, IL-4, and IL-10 were 
similar in children with asthma compared to healthy controls. 
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Figure 2 Transcription factor TBX21/gaTa-3, RORc/TBX21, and FOXP3/RORc ratios in asthmatics compared to healthy controls (hc).
Notes: Ratios are expressed as log transcription of TBX21/gaTa-3 and FOXP3/RORc. TBX21 directs the Th1 cellular program. gaTa-3 is specific for Th2 cells. RORc 
mRna transcript variant 2 was identified, and appears to be responsible for Th17 differentiation. The phenotype of cD4+cD25hi regulatory T cells (Tregs) is directed by the 
transcription factor FOXP3. The P values are indicated on the figure. 
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  Frequencies of CD4+ T cell-producing IFN-γ were signifi-
cantly reduced in asthmatic children (P = 0.0001) compared 
to healthy subjects.
After in vitro stimulation, frequencies of CD4+ T cells 
staining positively for IL-2 and IL-10 were similar in asth-
matics and healthy controls (Table 2). The frequencies of 
CD4+ T cell-producing IL-4 were significantly higher in 
asthma patients than in the healthy control group after in vitro 
stimulation; in contrast, a significantly low level of IFN-γ was 
observed in asthmatic children (P = 0.0001).
Discussion
Asthma arises from multiple interactions of infiltrating and 
structural cells in the context of chronic airway inflamma-
tion that is orchestrated by Th1, Th2, Th17, and Treg cells.20 
Recent data indicates that a deficient control of presumed 
pathogenic Th2- and Treg-mediated mechanisms may be 
involved in asthma.22 This study assessed the expression of 
CD4-related transcription factors on PBMC to evaluate the 
balance between circulating Th subpopulations in young 
asthmatics. PBMC cells from asthmatic patients were asso-
ciated with a low expression of FOXP3, a marker of Treg 
cells. In addition, the study found a high expression of the 
regulatory factor EBI3 in asthmatics compared with control 
groups. The expression of GATA-3 and RORC, the Th2 and 
Th17-associated transcription factors themselves, exhibited a 
higher increase in asthmatic patients. Using stimulated CD4+ 
T cell-producing cytokines, the study found significantly 
higher frequencies of CD4+ T cells expressing IL-4 compared 
to healthy children. Similarly to other reports, stimulated 
T cells were accompanied by significantly decreased IFN-γ 
production in patients with asthma, as compared to age-
matched healthy controls.
The number of circulating Tregs in peripheral blood 
was significantly altered in asthmatic patients, as recently 
reported.23 In the current study, the data reported decreased 
expression of FOXP3 in asthmatic children. The stability 
of FOXP3 in Treg cells could be diminished under strong 
inflammatory conditions.24,25 Provoost et al reported a 
deficiency in FOXP3 protein expression within CD4+CD25+ 
T cells of asthmatic patients.26 Recent studies have elegantly 
demonstrated that FOXP3+ T cells expressing T-bet, IRF4, or 
STAT3 specifically suppress the Th1, Th2, or Th17 response 
in vivo, respectively.26
This study found high levels of EBI3 expression in asth-
matic patients. EBI3 was found to constitute a part of IL-35, 
a cytokine associated with immunosuppressive effects of 
Tregs in mice.4,27 EBI3 receptor signaling influences a vari-
ety of immune cell types and can inhibit both Th1 and Th2 
responses. Recently Dokmeci et al reported that EBI3 might 
play an inhibitory role in allergic asthma development.28 
EBI3 in human immune regulation is not confirmed and 
more data are needed. A straight interaction exists between 
Th1, Th2, Th17, and Treg cells under the influence of many 
factors (TGF-β, retinoic acid, IL-6, IL-17, IL-10, etc)29 and 
a conversion from one kind to another population is possible. 
Treg cells can become IL-17-producing cells upon stimula-
tion with IL-6 and low concentration of TGF-β. Recently it 
was reported that naturally regulatory T cells (nTreg) and 
FOXP3 were discovered as immune suppressors critical for 
self-tolerance and immune homeostasis. These nTreg cells 
were shown to convert into proinflammatory cells.30
Observations of increased expression of IL-17 in 
blood and in inflammatory sites support a Th17-mediated 
pathogenesis.31,32 The Th17/Treg ratio was found to be sig-
nificantly higher in asthmatics, and this finding is compatible 
with a role for Th17 as an inflammatory factor in asthma. The 
young patients were characterized in their sera by a significant 
increase of IL-6 and IL-17 cytokines having a prominent 
role in inflammation in childhood asthma. Analysis of the 
distribution of Th17 cells revealed the presence of inflam-
mation occurring when the number of Th17 cells exceeds the 
number of Th1 cells.31 Such a situation was observed in the 
asthmatic patients group where Th17 cells exceed Th1 cells. 
A wide range of Th17/Th1 ratios permitted exacerbation of 
the disease. In asthma patients, Th17 differentiated cells are 
Table 2 Percentage of cD4+ T cells producing Il-2, Il-4, Il-10, and IFn-γ spontaneously and after in vitro stimulation (data are shown 
as mean ± se)
IL-2 IL-4 IL-10 IFN -γ
Spontaneously Asthmatics 3.24% ± 0.17% 3.22% ± 0.36% 3.52% ± 0.51% 1.86% ± 0.43%*
hc 3.92% ± 0.28% 3.19% ± 0.22% 4.06% ± 0.46% 3.52% ± 0.92%
After stimulation Asthmatics 6.09% ± 0.45% 9.58% ± 0.43%* 7.92% ± 0.5% 6.72% ± 0.39%*
hc 6.21% ± 0.33% 5.60% ± 0.39% 8.58% ± 0.47% 12.5% ± 1.92%
Notes: *P , 0.05; no differences were observed in Il-2 and Il-10 synthesis between healthy controls and asthmatics, spontaneously and after stimulation.
Abbreviation: hc, healthy controls.Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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able to release IL-17. Th17 cells also induced IFN-γ (Th1) 
production.33,34 In the patients, the high Th17/Th1 ratio in 
asthmatics indicated low IFN-γ–CD4+ T cells production 
spontaneously and after in vitro stimulation. The role of IFN-γ 
in the pathogenesis of asthma is more complex. Regarding 
the wide range production of proinflammatory cytokines 
by Th17 cells (IL-17), it is expected that Th17 is a potent 
pathogenic factor in disease immunopathophysiology, in 
particular, in asthma.
Interplay between Treg and Th17 probably exist in asthma. 
The overexpression of RORC2 in naïve T cells reduces   levels 
of FOXP3; small interfering   RNA-mediated knockdown 
of RORC2 enhances its expression. RORC2 mediates this 
inhibition at least partially by binding to two out of four 
ROR-responsive elements on the FOXP3 promoter.35 RORC 
promotes high FOXP3 levels and decreased expression of 
proinflammatory cytokines. Burgler et al identified RORC2 
as a polarizing factor in transcriptional cross-regulation 
and provides novel viewpoints on the control of immune 
tolerance versus effector immune responses.35 Unexpect-
edly, as reported recently by Ayyoub et al, a significant 
proportion of circulating memory FOXP3+ Tregs secrete 
IL-17 and express high levels of RORγt ex vivo.36 These 
findings shed light on the close relationship between human 
Tregs and Th17 cells and suggest that, in addition to their 
well-recognized immune suppressive functions, memory 
FOXP3+ Treg cells likely play additional, yet to be described, 
proinflammatory functions.37 Future studies addressing these 
issues will undoubtedly contribute to further elucidation of 
the mechanisms regulating the balance between inflamma-
tion and homeostasis in asthma.
These data are consistent with a recent report demonstrat-
ing that TBX21 T-1993C polymorphism represses TBX21 
expression and Th1 cytokine production through control 
of YY1, which might result in the imbalance between Th1 
and Th2 immune responses in autoimmune or allergic 
diseases.37,38
The results show the plasticity existing between Th1, 
Th17, and Treg cells during young asthma. The study did not 
find significant differences of CD4+-IL-10 production after 
in vitro stimulation. This cytokine was reported to inhibit 
the production of IFN-γ of Th1 CD4+ cell clones via its 
ability to abrogate the production of monocyte/macrophage 
cytokines such as IL-12. 39,40 It is well recognized that IL-10 
is produced by Th1, Th2, Th17, and particularly by Treg cells 
(CD4+CD25+FOXP3+), and that the transcription factors 
TBX21, GATA-3, RORC, and FOXP3 can be co-expressed 
in some Treg cells and exist in vivo.33
A critical role for T cells, and especially Th17 and Treg 
cells, in young asthmatics is now widely accepted. The 
precise effects of TBX21 and GATA-3 in the pathogenesis 
of asthma are still not fully understood and the finding of 
overexpression of RORC and underexpression of FOXP3 in 
asthma suggests that these proteins have a significant role 
in this process.
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